Doctors Urge Fed. Circ. To Keep Cholesterol Drug On Market
Cardiologists and other medical practitioners filed amicus briefs Tuesday urging the Federal Circuit to stop a permanent injunction issued earlier this month that would pull Sanofi's cholesterol-lowering drug Praluent off the...To view the full article, register now.
Already a subscriber? Click here to view full article